The Role of the New Ca2+ Antagonist, CV159, in Hepatic I/R Injury—The Evaluation of Hepatic Organ Reducing Activity Using In Vivo and Ex Vivo EPR

Autor: Watanabe, Taiji, Oowada, Shigeru, Kobayashi, Hiromichi P., Kamibayashi, Masato, Ishiuchi, Atsuko, Jinnouchi, Yuji, Koizumi, Satoshi, Asano, Takayuki, Shimamura, Tsukasa, Asakura, Takeshi, Nakano, Hiroshi, Kubota, Sunao, Otsubo, Takehito
Zdroj: In Journal of Surgical Research 2008 145(1):49-56
Databáze: ScienceDirect
Externí odkaz: